ENDP

Endo Announces Resolution of Government Investigation

[PR Newswire] – MALVERN, Pa., Feb. 21, 2014 /PRNewswire/ — Endo Pharmaceuticals, a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), announced today that it has reached a resolution of criminal and civil claims … moreView todays social media effects on ENDPView the latest stocks trending across Twitter. Click to view dashboardSee who Endo is hiring next, click here to […]

Endo to Announce Fourth Quarter 2013 Financial Results on February 28, 2014

[at noodls] – MALVERN, Pa., Feb. 20, 2014 /PRNewswire/ — Endo Health Solutions (Nasdaq: ENDP) will announce its fourth quarter 2013 financial results before the open of the U.S. financial markets on February 28, 2014 … moreView todays social media effects on ENDPView the latest stocks trending across Twitter. Click to view dashboardSee who Endo is hiring next, click here […]

Endo Announces 2013 Non-Cash Charges

[PR Newswire] – MALVERN, Pa., Feb. 19, 2014 /PRNewswire/ — Endo Health Solutions (Nasdaq: ENDP) today announced that it has completed its annual goodwill and in-process research and development (IPR&D) impairment analysis … moreView todays social media effects on ENDPView the latest stocks trending across Twitter. Click to view dashboardSee who Endo is hiring next, click here to view […]

8:33 am Endo Health announces South African Competition Act Compliance and approval under the Investment Canada Act in connection with its proposed acquisition of Paladin Labs

moreView todays social media effects on ENDPView the latest stocks trending across Twitter. Click to view dashboardSee who Endo is hiring next, click here to view […]

Endo Announces South African Competition Act Compliance and Approval Under the Investment Canada Act in Connection with Its Proposed Acquisition of Paladin Labs

[PR Newswire] – MALVERN, Pa., Feb. 18, 2014 /PRNewswire/ — Endo Health Solutions (ENDP) today announced that the South African Competition Commission has completed its review and approved the merger of Endo and Paladin Labs without conditions in terms o moreView todays social media effects on ENDPView the latest stocks trending across Twitter. Click to view dashboardSee who Endo is […]

PropThink: ENDP Validates That New Opana ER Formulation Reduces Abuse; Stock Should Respond Favorably

[ACN Newswire] – By Jake KingAgainst a backdrop of growing opioid abuse in the U.S., Endo Health Solutions (NASDAQ:ENDP) announced another step Monday night in its efforts to curb abuse of its older, first generation pain … moreView todays social media effects on ENDPView the latest stocks trending across Twitter. Click to view dashboard […]

PropThink: ENDP’s Lower Guidance Not Much Of A Surprise; Negative Sentiment Remains An Opportunity

[ACN Newswire] – By David MoskowitzEndo Pharmaceuticals (NASDAQ:ENDP) reported 3Q 2012 adjusted EPS of $1.28, ahead of the Consensus estimate of $1.26. However, revenues for the period came in at $750.5 million vs. Street … moreView todays social media effects on ENDPView the latest stocks trending across Twitter. Click to view dashboard […]